Scared off hormone therapy by the headlines? Here’s what the research actually shows about HRT benefits and risks, and what decides whether it’s right for you.
For many women, the hormone therapy conversation never happened.
Not because it wasn’t right for them. Because they were scared out of ever asking.
Breast cancer. Heart disease. Dementia. Those words hung over hormone therapy for more than twenty years. They stopped millions of women from asking about it, and millions of providers from bringing it up. Meanwhile, hot flashes got managed with whatever else was available, sleep problems got treated with sedatives, and mood changes got chalked up to stress.
The real picture is more nuanced than the headline that scared you.
If you closed the door on hormone therapy years ago because of what you heard, the conversation is worth reopening. Not because hormone therapy is risk-free, and not because it’s right for everyone, but because you deserve the full picture.
This post covers how we got here, what the research shows now, the real benefits and risks, and what I look at from a functional medicine perspective to help women decide. Numbers in brackets point to the references at the end.
In 2002, the Women’s Health Initiative (WHI), one of the largest hormone therapy trials ever done, stopped its estrogen-plus-progestin arm early after finding small increases in breast cancer, heart disease, stroke, and blood clots.[1] The headlines were enormous. Within months, millions of women stopped taking hormones, and prescribing fell sharply.
additional breast cancer cases per year of use
Here’s what often got lost:
The average participant was 63, and most were well past menopause. That’s very different from a woman starting hormone therapy at 50 for hot flashes.
Oral conjugated equine estrogens combined with a synthetic progestin (medroxyprogesterone acetate). That’s not what most women are prescribed today.
“26% higher breast cancer risk” sounds frightening. In absolute terms, the difference was about 8 additional cases per 10,000 women taking it for a year.[1]
None of that makes the findings meaningless. They’re real. It means the headline was one chapter, and the story kept going.
When analyses looked at women by age, the pattern shifted. Women who started hormone therapy under 60, or within about ten years of menopause, had a more favorable balance of benefits and risks than women who started later.[2], [3] Current expert guidance reflects that.[3]
Guidelines call for the lowest effective dose for the shortest time that meets your goals, reviewed regularly, not a one-size-fits-all prescription.[3] (Here’s how hormone therapy dosing really works.)
| Benefits | What the Research Shows |
|---|---|
| Hot flashes and night sweats | The most effective treatment available; roughly a 75% reduction in frequency versus placebo[11] |
| Vaginal and urinary symptoms | Effective, and low-dose vaginal estrogen works with minimal absorption |
| Bone | Reduces bone loss and lowers fracture risk[12] |
| Sleep and mood | Often improves sleep and, for some women in perimenopause, mood (see anxiety or perimenopause?) |
| Risks & Limits | What the Research Shows |
|---|---|
| Blood clots | Oral estrogen increases risk; transdermal appears lower[7] |
| Stroke | Small increase with oral estrogen, lower with transdermal[8] |
| Breast cancer | Small increase with long-term combined estrogen and progestogen use; not seen with estrogen alone in the WHI[4], [9] |
| Heart disease | Not recommended to prevent heart disease. Starting under 60 or near menopause is generally considered favorable[2], [3] |
| Dementia | Not recommended to prevent dementia. In women 65 and older who started combined hormones, risk was higher[13] |
For a closer look at breast cancer specifically, read my post on hormone therapy and breast cancer.
Hormone therapy is one option among several. If you’re not sure where your symptoms fit, my free Hormone Type Assessment is a short quiz that helps you see whether your symptoms point toward:
The question isn’t “is hormone therapy safe?” It’s “is it right for you, at your age, with your history?” That’s a personal risk and benefit conversation. These are the pieces I look at:
Breast, ovarian, and uterine cancers; blood clots; stroke; heart disease; and migraine with aura.
How old you are, and how long since your last period.
Blood pressure, cholesterol and triglycerides, fasting glucose, insulin, and A1c, plus liver enzymes. Cardiometabolic health shapes your risk.
An up-to-date mammogram and breast density, plus cervical and colon screening. (See what proactive breast health looks like.)
Alcohol, weight, smoking, activity, and sleep. For example, alcohol raises breast cancer risk in a dose-related way,[14] and it’s something you control, whatever you decide about hormones. (More on alcohol.)
What bothers you most, and what you hope to gain.
I also use my four working patterns to organize the picture:
Hot flashes, night sweats, wired at night, tired by day
Low energy, dry skin, hair shedding, slow recovery
Blood sugar swings, cravings, stubborn midsection weight
Bloating, breast tenderness, puffiness, alcohol hitting harder
These are clues that organize questions. They don’t diagnose a cause.
Hormone therapy isn’t appropriate for everyone. Your provider will likely advise against it, or approach it very carefully, if you have:
If you have a uterus and take estrogen, you also need a progestogen alongside it to protect the lining.
Aim for the lowest effective dose. I cover this in my post on how dosing really works.
Transdermal is often preferred if you have clot or cardiovascular risk factors.
It protects the uterine lining.
At least yearly, with your symptoms, blood pressure, and screenings.
Mammograms, cervical, and colon screening.
Strength training, protein, sleep, and less alcohol support your bones, mood, and metabolism whether or not you use hormones. (Why muscle matters.)
That’s a valid choice too. Non-hormonal options can help with hot flashes, and they’re worth discussing with your provider.[15] Sleep, strength training, and managing triggers help too. The goal is a plan you feel good about.
If you’re already on hormone therapy, call your provider or seek emergency care promptly for leg pain or swelling on one side, chest pain, shortness of breath, sudden vision changes, a sudden severe headache, weakness, or trouble speaking. Also report heavy or unexpected vaginal bleeding.
A decision you made years ago, based on a headline, doesn’t have to be the final one. Maybe hormone therapy isn’t right for you. Maybe it is. Either way, you deserve to make that choice with the full picture.
If you haven’t yet, start with the free Hormone Type Assessment. And if you’d rather talk through your own situation, I offer a free discovery call. No pressure, just a conversation about whether functional medicine is the right next step for you.
Book Your Free Discovery Call →To your health and vitality, Dr. Ryan
For many healthy women who start hormone therapy under 60 or within about ten years of menopause, the benefits generally outweigh the risks. It isn’t right for everyone, and the decision depends on your age, health history, and the type and route of therapy.
Long-term combined estrogen and progestogen use is linked to a small increase in breast cancer risk, about 8 additional cases per 10,000 women per year in the WHI. Estrogen alone did not increase risk in the WHI, and long-term follow-up showed a lower rate.
Transdermal estrogen (patch or gel) appears to carry a lower risk of blood clots and stroke than oral estrogen because it bypasses first-pass processing in the liver. It’s often preferred for women with clot or cardiovascular risk factors.
The 2002 WHI estrogen-plus-progestin trial found small increases in breast cancer, heart disease, stroke, and blood clots. Participants averaged 63 and were mostly well past menopause, and one specific oral regimen was tested. Later analyses showed timing, type, and route matter.
Women with a history of breast or other estrogen-sensitive cancer, blood clots, stroke, heart disease, active liver disease, or unexplained vaginal bleeding usually aren’t good candidates, or need a very careful approach with their providers.
For educational purposes only. Not a diagnosis, and not a substitute for care from your healthcare provider. Do not start, stop, or change any medication, including hormone therapy, without talking with your prescriber.